Position in JNJ
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$38,340,326
+$1,049,783 QoQ
Shares Held
150,964
-1.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#516
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glenview Trust Co holds $465,808,551 across 12 Drug Manufacturers - General names. JNJ ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
188,484 | $226,073,382 | |
| 2 | ABBV |
AbbVie Inc.
|
422,207 | $106,244,168 | |
| 3 | MRK |
Merck & Co., Inc.
|
381,609 | $49,036,756 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
150,964 | $38,340,326 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
195,795 | $24,736,739 | |
| 6 | PFE |
Pfizer Inc
|
442,787 | $10,662,310 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
102,223 | $5,890,089 | |
| 8 | AMGN |
Amgen Inc
|
8,321 | $3,013,200 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,340,326 | 150,964 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $37,290,543 | 152,555 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $31,408,801 | 151,770 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $27,851,195 | 150,206 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $23,033,936 | 150,795 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $24,986,117 | 150,664 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $22,182,393 | 153,384 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $25,506,623 | 157,390 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $22,967,289 | 157,138 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $24,964,279 | 157,812 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $25,025,420 | 159,662 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $24,712,228 | 158,666 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $26,120,049 | 157,806 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $24,166,825 | 155,915 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $27,454,235 | 155,416 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $24,653,310 | 150,914 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $27,072,582 | 152,513 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $26,842,724 | 151,457 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $25,916,591 | 151,497 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $23,024,893 | 142,569 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $23,324,712 | 141,585 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $22,929,289 | 139,515 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $23,278,390 | 147,912 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $22,170,911 | 148,918 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $20,971,729 | 149,127 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $19,636,454 | 149,748 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||